21 – 30 of 95
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
- 2022
-
Mark
Landscape of surfaceome and endocytome in human glioma is divergent and depends on cellular spatial organization
2022) In Proceedings of the National Academy of Sciences of the United States of America 119(9). p.1-11(
- Contribution to journal › Article
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
(
- Contribution to journal › Article
-
Mark
Transcriptional profiling demonstrates altered characteristics of CD8 + cytotoxic T-cells and regulatory T-cells in TP53-mutated acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Mixed Phenotype/Lineage Leukemia : Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?
(
- Contribution to journal › Scientific review
-
Mark
The immune cell atlas of human neuroblastoma
(
- Contribution to journal › Article
- 2021
-
Mark
Generating Dendritic Cells by Direct Cell Reprogramming. Merging cellular reprogramming with immunology towards the development of novel cancer immunotherapies.
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
(
- Contribution to journal › Article
-
Mark
Pattern recognition receptor expression and maturation profile of dendritic cell subtypes in human tonsils and lymph nodes
(
- Contribution to journal › Article
-
Mark
Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine
(
- Contribution to journal › Article